Operating
Accrued Interest Earned, Investments
Veradermics Accrued Interest Earned, Investments remained flat by 0.0% to $161.75K in Q4 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalHigher is better
VolatilityStable
First reportedQ1 2024
Last reportedQ4 2025Mar 30, 2026
How to read this metric
An increase indicates growing interest-bearing assets, while a decrease suggests maturing investments or lower interest rates.
Detailed definition
This represents interest income that has been earned on the company's investment portfolio but has not yet been received...
Peer comparison
Standard for any company holding significant marketable securities.
Metric ID:
operating_accrued_interest_earned_investmentsHistorical Data
2 years
| FY'24 | FY'25 | |
|---|---|---|
| Value | $0.00 | $647.00K |
Range$0.00 – $647.00K
Accrued Interest Earned, Investments at Other Companies
Frequently Asked Questions
- What is Veradermics 's accrued interest earned, investments?
- Veradermics (MANE) reported accrued interest earned, investments of $161.75K in Q4 2025.
- What does accrued interest earned, investments mean?
- Interest earned on investments that has not yet been paid in cash.